Exploiting the Yeast L-A Viral Capsid for the In Vivo Assembly of Chimeric VLPs as Platform in Vaccine Development and Foreign Protein Expression

Frank Powilleit, Tanja Breinig, Manfred J. Schmitt · 2007

Read Exploiting the Yeast L-A Viral Capsid for the In Vivo Assembly of Chimeric VLPs as Platform in Vaccine Development and Foreign Protein Expression by Frank Powilleit, Tanja Breinig, Manfred J. Schmitt (2007) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0000415.txt.

Description

Frank Powilleit, Tanja Breinig, and Manfred J. Schmitt turned a yeast virus's shell into a building platform, reporting in PLOS ONE in 2007. The L-A virus of yeast wraps itself in a protein capsid. The team used that capsid inside living yeast to assemble chimeric virus-like particles, shells that mix the original protein with foreign pieces.

Virus-like particles are prized in vaccine work because they look like viruses to the immune system but cannot cause infection. A yeast-based assembly line could make them cheaply, and the same platform can display foreign proteins for research. The study is a piece of bioengineering: borrowing a virus's carpentry for human purposes.

Catalog record

CREATORFrank Powilleit, Tanja Breinig, Manfred J. Schmitt
YEAR2007
COLLECTIONPAPERS
FORMATTXT
FILE SIZE50 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0000415

Browse the full library · About the Tower of Babel